Covid: U.S. study halves risk of admission to Omigron Hospital – North America

(ANSA) – Washington, Jan 12 (Xinhua) – Extensive research by U.S. scientists on about 70,000 Govt-positive patients (not yet verified by colleagues) has significantly reduced the risk of hospital admission and death due to the Omigron variant than the Delta. Regardless of the level of immunity in the population. Patients with Omicron disease were less than half as likely to be hospitalized than those with Delta, while the risk of ending intensive care was reduced by about 75% and the risk of death was reduced by 90%. Of the more than 52,000 people in Omicron, 11 out of 17,000 in Delta do not need a ventilator. Furthermore, Omicron was hospitalized for an average of 1.5 days compared to 5 for Delta.

The study, which confirms data collected by other countries such as South Africa and Great Britain, was conducted by researchers at the University of California, Berkeley, Kaiser Permanente and the US federal program CDC on the spread of the disease. (Handle).

Reproduction Assigned by © Copyright ANSA